U.K. to fund Phase III trial of Indevus' PRO 2000

Indevus (IDEV) said that the U.K. government and Medical Research Council will provide L26 million ($48.6 million) to fund a Phase III trial of PRO 2000 gel to prevent sexually acquired HIV infection ...